A carregar...
NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
BACKGROUND: Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax (SET) domain-containing 2 (NSD2), is a well-known histone lysine methyltransferase (HMTase). The aim of this study was to investigate the biological role of NSD2 in clear cell renal cell carcinoma (ccRCC). METHO...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974414/ https://ncbi.nlm.nih.gov/pubmed/32021450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S222673 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|